Comparison of the effect between pegaptanib and ranibizumab on exudative age-related macular degeneration with small lesion size
Yoshihiro Nishimura1,2, Maiko Taguchi1, Takafumi Nagai1, Masashi Fujihara1,2, Shigeru Honda2, Mamoru Uenishi11Department of Ophthalmology, Mitsubishi Kobe Hospital, Kobe, Japan; 2Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe, JapanPurpose: To com...
Main Authors: | Fujihara M, Nagai T, Taguchi M, Nishimura Y, Honda S, Uenishi M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2012-03-01
|
Series: | Clinical Ophthalmology |
Online Access: | http://www.dovepress.com/comparison-of-the-effect-between-pegaptanib-and-ranibizumab-on-exudati-a9418 |
Similar Items
-
CLINICAL OUTCOMES OF THE TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH PEGAPTANIB
by: M. Burova, et al.
Published: (2015-12-01) -
Clinical outcomes of the treatment of exudative age-related macular degeneration with Pegaptanib
by: M. Burova, et al.
Published: (2013-02-01) -
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation
by: J Colquitt, et al.
Published: (2008-05-01) -
Results of switchback from ranibizumab to aflibercept in patients with exudative age-related macular degeneration
by: Koike N, et al.
Published: (2019-07-01) -
Results of Intravitreal Ranibizumab Treatment for Exudative Age-Related Macular Degeneration
by: Umut Karaca, et al.
Published: (2012-01-01)